Document:

Exhibit 10.4

 

FORM OF

COMMON STOCK PURCHASE AGREEMENT

COMMON STOCK PURCHASE
AGREEMENT (the “Agreement”), dated as of June 29, 2021, by and between CDISTRO, INC., a Nevada corporation
(the “Company”), and MARIJUANA COMPANY OF AMERICA, INC., a Utah corporation (the “Buyer”).
Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.

WHEREAS:

Subject to the terms and
conditions set forth in this Agreement, the Company wishes to sell to the Buyer, and the Buyer wishes to buy from the Company, Three Hundred
Fifty Thousand ($350,000) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at the
price of $1.00 per share. The shares of Common Stock to be purchased hereunder are referred to herein as the “Commitment Shares.”

NOW THEREFORE, the
Company and the Buyer hereby agree as follows:

 

	 	1.	PURCHASE OF COMMON STOCK. 

Subject to the terms
and conditions set forth in this Agreement, the Company has the right to sell to the Buyer, and the Buyer has the obligation to purchase
from the Company, Commitment Shares as follows:

Purchases of Common
Stock. Buyer shall purchase from the Company the Commitment Shares and pay to the Company as the purchase price therefor, via wire
transfer, Three Hundred Fifty Thousand Dollars ($350,000) (such purchase the “Purchase”). The parties acknowledge the
prior deposit of $35,000 into escrow with Independent Law, PLLC towards the Purchase. Upon issuance and payment therefor as provided herein,
such Commitment Shares shall be validly issued and are fully paid and non-assessable. The Commitment Shares shall be issued with restrictive
legend.

 

	 	2.	BUYER’S REPRESENTATIONS AND WARRANTIES. 

The Buyer represents
and warrants to the Company that as of the date hereof and as of the Commencement Date:

(a) Investment Purpose.
The Buyer is entering into this Agreement and acquiring the Commitment Shares (the “Securities”), for its own account
for investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof; provided however,
by making the representations herein, the Buyer does not agree to hold any of the Securities for any minimum or other specific term.

(b) Accredited Investor
Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a)(3) of Regulation D.

(c) Information.
The Buyer has been furnished with all materials relating to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities that have been reasonably requested by the Buyer. The Buyer understands that its investment in
the Securities involves a high degree of risk. The Buyer (i) is able to bear the economic risk of an investment in the Securities
including a total loss, (ii) has such knowledge and experience in financial and business matters that it is capable of evaluating
the merits and risks of the proposed investment in the Securities and (iii) has had an opportunity to ask questions of and receive
answers from the officers of the Company concerning the financial condition and business of the Company and other matters related to an
investment in the Securities.

(d) No Governmental
Review. The Buyer understands that no United States federal or state agency or any other government or governmental agency has passed
on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor
have such authorities passed upon or endorsed the merits of the offering of the Securities.

(e) Validity; Enforcement.
This Agreement has been duly and validly authorized, executed and delivered on behalf of the Buyer and is a valid and binding agreement
of the Buyer enforceable against the Buyer in accordance with its terms, subject as to enforceability to general principles of equity
and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally,
the enforcement of applicable creditors’ rights and remedies.

 

    	1  

    	 

    

 

	 	3.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY. 

The Company represents
and warrants to the Buyer that as of the date hereof and as of the Commencement Date:

(a) Organization and
Qualification. The Company is a corporation duly organized and validly existing in good standing under the laws of the State of Nevada
and has the requisite corporate power and authority to carry on its business as now being conducted.

(b) Authorization; Enforcement;
Validity. (i) The Company has the requisite corporate power and authority to enter into and perform its obligations under this
Agreement, and each of the other agreements entered into by the parties on the Commencement Date and attached hereto as exhibits to this
Agreement (collectively, the “Transaction Documents”), and to issue the Securities in accordance with the terms hereof
and thereof, (ii) the execution and delivery of the Transaction Documents by the Company and the consummation by it of the transactions
contemplated hereby and thereby, including without limitation, the issuance of the Commitment Shares and the reservation for issuance
and the issuance of the Commitment Shares issuable under this Agreement, have been duly authorized by the Company’s Board of Directors
or duly authorized committee thereof, do not conflict with the Company’s Certificate of Incorporation or Bylaws, and do not require
further consent, approval or authorization by the Company, its Board of Directors or its shareholders, (iii) this Agreement has been,
and each other Transaction Document shall be on the Commencement Date, duly executed and delivered by the Company and (iv) this Agreement
constitutes, and each other Transaction Document upon its execution on behalf of the Company, shall constitute, the valid and binding
obligations of the Company enforceable against the Company in accordance with their terms, except as such enforceability may be limited
by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally, the enforcement of creditors’ rights and remedies. The Board of Directors of the Company or duly authorized
committee thereof has approved and authorized this Agreement and the transactions contemplated hereby.

(c) Capitalization.
As of the date hereof, the authorized capital stock of the Company consists of (i) 1,350,000 shares of Common Stock, of which as
of the date hereof, 1,000,000 shares are issued and outstanding, and 350,000 shares reserved for issuance or purchase pursuant to this
Agreement and (ii) no shares of Preferred Stock. All of such outstanding shares have been, or upon issuance will be, validly issued
and are fully paid and nonassessable. No shares of the Company’s capital stock are subject to preemptive rights or any other similar
rights or any liens or encumbrances suffered or permitted by the Company, (ii) there are no outstanding debt securities, (iii) there
are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or
securities or rights convertible into, any shares of capital stock of the Company, or contracts, commitments, understandings or arrangements
by which the Company is or may become bound to issue additional shares of capital stock of the Company or options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of
capital stock of the Company, (iv) there are no agreements or arrangements under which the Company is obligated to register the sale
of any of their securities under the 1933 Act, (v) there are no outstanding securities or instruments of the Company which contain
any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company is
or may become bound to redeem a security of the Company, (vi) there are no securities or instruments containing anti-dilution or
similar provisions that will be triggered by the issuance of the Securities as described in this Agreement and (vii) the Company
does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement. The Company
has furnished or made available to the Buyer true and correct copies of the Company’s Certificate of Incorporation, as amended and
as in effect on the date hereof (the “Certificate of Incorporation”), and the Company’s By-laws, as amended and
as in effect on the date hereof (the “By-laws”), and summaries of the terms of all securities convertible into or exercisable
for Common Stock, if any, and copies of any documents containing the material rights of the holders thereof in respect thereto.

    	2  

    	 

    

 

(d) Issuance of Securities.
The Commitment Shares have been duly authorized and, upon issuance in accordance with the terms hereof, the Commitment Shares shall be
(i) validly issued, fully paid and non-assessable and (ii) free from all taxes, liens and charges with respect to the issue
thereof. Upon issuance and payment therefor in accordance with the terms and conditions of this Agreement, the Commitment Shares shall
be validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof, with the
holders being entitled to all rights accorded to a holder of Common Stock.

(e) No Conflicts.
The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions
contemplated hereby and thereby (including, without limitation, the reservation for issuance and issuance of the Commitment Shares) will
not result in a violation of the Certificate of Incorporation or the By-laws of the Company.

 

	 	4.	MISCELLANEOUS.

(a) Governing Law;
Jurisdiction; Jury Trial. The corporate laws of the State of Nevada shall govern all issues concerning the relative rights of the
Company and its shareholders. All other questions concerning the construction, validity, enforcement and interpretation of this Agreement
and the other Transaction Documents shall be governed by the internal laws of the State of Nevada, without giving effect to any choice
of law or conflict of law provision or rule (whether of the State of Nevada or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of Nevada. Each party hereby irrevocably submits to the exclusive jurisdiction of
the state and federal courts sitting in the City of Reno, for the adjudication of any dispute hereunder or under the other Transaction
Documents or in connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND
AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT
OR ANY TRANSACTION CONTEMPLATED HEREBY.

(b) Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were
an original, not a facsimile signature.

(c) Headings. The
headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.

(d) Severability.
If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any
provision of this Agreement in any other jurisdiction.

 

(e) Entire Agreement.
With the exception of the Mutual Nondisclosure Agreement between the parties dated as of March 19, 2021, this Agreement supersedes all
other prior oral or written agreements between the Buyer, the Company, their affiliates and persons acting on their behalf with respect
to the matters discussed herein, and this Agreement, the other Transaction Documents and the instruments referenced herein contain the
entire understanding of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein
or therein, neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters.
The Company acknowledges and agrees that is has not relied on, in any manner whatsoever, any representations or statements, written or
oral, other than as expressly set forth in this Agreement.

(f) Notices. Any
notices, consents or other communications required or permitted to be given under the terms of this Agreement must be in writing and will
be deemed to have been delivered: (i) upon receipt when delivered personally; (ii) upon receipt when sent by facsimile (provided
confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one Business
Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the
same. The addresses and facsimile numbers for such communications shall be:

    	3  

    	 

    

 

If to the Company:

cDistro, Inc.

3450 S. Ocean Blvd., #122

Palm Beach, FL 33480

Attention: Ronald P. Russo, Jr.

Email: rr@cdistro.com

If to the Buyer:

Marijuana Company of America, Inc.

1340 West Valley Parkway, Suite 205

Escondido, CA 92029

Attention: Jesus M. Quintero, CEO

Email: jesus@hempsmart.com

or at such other address and/or facsimile number
and/or to the attention of such other person as the recipient party has specified by written notice given to each other party one (1) Business
Day prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent
or other communication, (B) mechanically or electronically generated by the sender’s facsimile machine containing the time,
date, and recipient facsimile number or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence
of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause
(i), (ii) or (iii) above, respectively. Any party to this Agreement may give any notice or other communication hereunder using
any other means (including messenger service, ordinary mail or electronic mail), but no such notice or other communication shall be deemed
to have duly given unless it actually is received by the party for whom it is intended.

(g) Successors and Assigns.
This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns. The Company
shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Buyer, including by merger
or consolidation. The Buyer may not assign its rights or obligations under this Agreement.

(h) No Third Party Beneficiaries.
This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any other person.

(i) Publicity. The
Buyer shall have the right to approve before issuance any press release, SEC filing or any other public disclosure made by or on behalf
of the Company whatsoever with respect to, in any manner, the Buyer, its purchases hereunder or any aspect of this Agreement or the transactions
contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of the Buyer, to make any press
release or other public disclosure (including any filings with the SEC) with respect to such transactions as is required by applicable
law and regulations so long as the Company and its counsel consult with the Buyer in connection with any such press release or other public
disclosure at least two (2) Business Days prior to its release. The Buyer must be provided with a copy thereof at least two (2) Business
Days prior to any release or use by the Company thereof.

(j) Further Assurances.
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(k) Termination. This
Agreement may be terminated only as follows:

(i) By the Buyer
without any liability or payment to the Company, if pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary
case or any Person commences a proceeding against the Company, a Custodian is appointed for the Company or for all or substantially all
of its property, or the Company makes a general assignment for the benefit of its creditors, this Agreement shall automatically terminate
without any liability or payment to the Company without further action or notice by any Person. No such termination of this Agreement
under this Section 4(k)(i) shall affect the Company’s or the Buyer’s obligations under this Agreement with respect to
pending purchases and the Company and the Buyer shall complete their respective obligations with respect to any pending purchases under
this Agreement.

 

    	4  

    	 

    

 

(ii) In the event
that the Commencement shall not have occurred, the Company shall have the option to terminate this Agreement for any reason or for no
reason without any liability whatsoever of any party to any other party under this Agreement.

(iii) At any
time after the Commencement Date, the Company shall have the option to terminate this Agreement for any reason or for no reason by delivering
notice (a “Company Termination Notice”) to the Buyer electing to terminate this Agreement without any liability whatsoever
of any party to any other party under this Agreement. The Company Termination Notice shall not be effective until one (1) Business
Day after it has been received by the Buyer.

(iv) This Agreement
shall automatically terminate on the date that the Company sells and the Buyer purchases the full Available Amount as provided herein,
without any action or notice on the part of any party and without any liability whatsoever of any party to any other party under this
Agreement.

Any termination of this Agreement pursuant to
this Section 4(k) shall be effected by written notice from the Company to the Buyer, or the Buyer to the Company, as the case may
be, setting forth the basis for the termination hereof. The representations and warranties of the Company and the Buyer contained in Sections
2 and 3 hereof shall survive the Commencement and any termination of this Agreement.

(l) No Financial Advisor,
Placement Agent, Broker or Finder. The Company represents and warrants to the Buyer that it has not engaged any financial advisor,
placement agent, broker or finder in connection with the transactions contemplated hereby. The Buyer represents and warrants to the Company
that it has not engaged any financial advisor, placement agent, broker or finder in connection with the transactions contemplated hereby.
The Company shall be responsible for the payment of any fees or commissions, if any, of any financial advisor, placement agent, broker
or finder engaged by the Company relating to or arising out of the transactions contemplated hereby. The Company shall pay, and hold the
Buyer harmless against, any liability, loss or expense (including, without limitation, attorneys’ fees and out of pocket expenses)
arising in connection with any such claim.

(m) No Strict Construction.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules
of strict construction will be applied against any party.

(n) Remedies, Other
Obligations, Breaches and Injunctive Relief. Each party’s remedies provided in this Agreement shall be cumulative and in addition
to all other remedies available to it under this Agreement, at law or in equity (including a decree of specific performance and/or other
injunctive relief), no remedy of either party contained herein shall be deemed a waiver of compliance with the provisions giving rise
to such remedy and nothing herein shall limit either party’s right to pursue actual damages for any failure by other party to comply
with the terms of this Agreement. Each party acknowledges that a breach by it of its obligations hereunder will cause irreparable harm
to the other and that the remedy at law for any such breach may be inadequate. Each party therefore agrees that, in the event of any such
breach or threatened breach, the other party shall be entitled, in addition to all other available remedies, to an injunction restraining
any breach, without the necessity of showing economic loss and without any bond or other security being required.

(o) Failure or Indulgence
Not Waiver. No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor
shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other
right, power or privilege.

 

 

 

    	5  

    	 

    

 

 

IN WITNESS WHEREOF, the
Buyer and the Company have caused this Common Stock Purchase Agreement to be duly executed as of the date first written above.

 

	 	 	 
	THE COMPANY:
	 
	CDISTRO, INC.
	 	 
	By:	 	
    /s/ Ronald
    P. Russo, Jr.

	Name:	 	Ronald P. Russo, Jr. 
	Title:	 	Chief Executive Officer
	 
	BUYER:
	 
	MARIJUANA COMPANY OF AMERICA, INC.
	 	 
	By:	 	
    /s/ Jesus
    M. Quintero

	Name:	 	Jesus M. Quintero
	Title:	 	Chief Executive Officer

 

 

 

 

 

6Exhibit 10.5

 

 

FORM OF

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “Agreement”)
entered into between Ronald P. Russo, Jr. (“Executive”), and cDistro, Inc. (the “Company”), will
be effective upon execution by both parties.

 

	1. 	Position; Commencement Date.

 

Executive will be employed by the Company under this
Agreement in the position of Chief Executive Officer. The effective starting date of Executive’s employment is June 29, 2021 (the
“Commencement Date”).

 

	2. 	Duties.

 

As the Company’s Chief Executive Officer, the
Executive shall perform such duties and functions as are determined from time to time by the Company’s Board of Directors (the “Board”).
In the performance of his duties with the Company, Executive shall at all times comply with the written policies of the Company and be
subject to the reasonable direction of the Board.

 

	3. 	Term of Employment.

 

The Company shall continue to employ Executive for
a period of up to thirty-six (36) months, commencing on the Commencement Date and ending on June 30, 2024 (the “Contract Term”),
subject to earlier termination as set forth in Section 13 (“Termination of Employment”). After the initial thirty-six
month period, this Agreement shall continue for successive one-year periods thereafter, subject to the provisions of Section 13 below,
and upon the same terms and conditions, except as they may be modified by the parties in writing from time to time, and unless and until
written Notice shall be given by either party forty-five (45) days in advance of the end of the initial term or any successive one-year
period of the intention not to continue this Agreement (the “Notice Period”) followed by the continued performance
of this Agreement for the Notice Period by both parties. The Contract Term of this Agreement shall include all such extensions.

 

	4. 	Base Salary.

 

Executive’s annual
base salary will be $90,000.00 (Ninety Thousand Dollars and No Cents) and shall be paid in accordance with the regular payroll practices
of the Company, subject to withholdings required by law or authorized by Executive. Executive’s salary will be subject to review
annually by the Board, provided, however, that the Executive’s base salary shall not be reduced except in circumstances where the
Company is making proportional reductions in the salaries of all of its executives.   

 

	5. 	Executive Bonus Program.

 

For each full fiscal year during which Executive remains
employed under this Agreement, Executive will have an opportunity to earn a fiscal year-end bonus based upon performance and earnings
targets and other standards to be established by the Board for each such year and based upon the Board’s evaluations of Executive’s
fiscal year results. Bonuses will be determined and awarded in the Board’s discretion following completion of the Company’s
annual audit by independent auditors.

  

	6. 	Employee Benefit Programs.

 

Executive will be eligible to participate in, and be
covered by, the Company’s employee benefit programs, subject to any preconditions in those programs, upon Executive’s Commencement
Date. Specific programs currently in place include: health (physician, prescription, dental, vision) insurance for Executive and his family;
a short term and long term disability insurance plan; and group or individual life insurance in the amount of two times Executive’s
annual salary. In addition, Executive will be entitled to four weeks of paid personal time off (“PTO”) for each 12 months
Executive is employed by the Company.

 

    	1  

    	 

    

 

   

	7. 	Reimbursements.

 

Executive will be reimbursed on a regular basis for
reasonable, necessary and properly documented business and travel expenses incurred for the purpose of conducting the Company’s
business, subject to periodic review and approval of such expenditures by the Board.

 

	8. 	Conflicting Employment.

 

Executive shall devote the professional time and attention
required to perform Executive’s obligations under this Agreement, and shall at all times faithfully, industriously and to the best
of Executive’s ability, experience and talent perform all of Executive’s obligations under this Agreement.

 

	9. 	Noncompetition.

 

Executive agrees that while he is employed by the Company
and for a 6-month period following the Contract Term, Executive will not within the State of Nevada directly or indirectly compete with
the Company by accepting employment or consulting contracts or performing activities for Executive’s own benefit or with or without
compensation for the benefit of another (a) with respect to any business which competes with that of the Company and (b) where the activities
performed by Executive are substantially similar to those performed by Executive for the Company under this Agreement.

 

	10. 	Non-Disparagement.

 

Executive agrees and covenants that, while he is employed
by the Company and for a five (5) year period following the Contract Term, he will not at any time make, publish or communicate to any
person or entity or in any public forum any defamatory or disparaging remarks, comments, or statements concerning the Company, any products,
services, or operations of the Company, or any of the former, current, or future officers, directors, or employees of the Company. This
Section does not, in any way, restrict or impede Executive from exercising protected rights to the extent that such rights cannot be waived
by agreement or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized
government agency, provided that such compliance does not exceed that required by the law, regulation, or order. The Executive shall promptly
provide written notice of any such order to the Board.

 

	11. 	Confidential Information.

 

(a)     Confidentiality.
Except as herein provided, Executive agrees that during and after termination of his employment with the Company, he (i) shall keep Confidential
Information (as defined below) confidential and shall not directly or indirectly, use, divulge, publish or otherwise disclose or allow
to be disclosed any aspect of Confidential Information without the prior written consent of the Board except in the performance of Executive’s
duties for Company; (ii) shall refrain from any action or conduct which might reasonably or foreseeably be expected to compromise the
confidentiality or proprietary nature of the Confidential Information; and (iii) shall follow the written directives made by the Board
of Directors from time to time regarding Confidential Information.

  

For purposes of this Agreement “Confidential
Information” includes but is not limited to trade secrets, confidential information, knowledge or data of the Company, or any
of its clients, customers, consultants, shareholders, licensees, licensors, vendors or affiliates, that Executive may produce, obtain
or otherwise acquire or have access to during the course of his employment by the Company (whether before or after the date of this Agreement),
including but not limited to: business plans, records, customer files and lists; sales practices; strategies and plans; sources of supply
and vendors; special business relationships with vendors, agents, and brokers; promotional materials and information; financial matters;
mergers; acquisitions; confidential personnel matters; inventions; developments; product specifications; procedures; pricing information;
intellectual property; technical data; software programs; finances; operations and production costs; ideas; plans technology; proposals;
market analysis; technical services; customer needs; customer purchasing patterns; customer renewal or expiration data; customer concerns;
Company pricing, rental or lease rates, and profit margins; Company’s commissions and/or fees; insurer information unique to or
tailored to Company; and other information which Company has developed at significant expenditure of time, effort and/or expense. All
Confidential Information and all tangible materials containing Confidential Information are and shall remain the sole property of the
Company.

 

    	2  

    	 

    

 

 

(b)     Limitation.
Executive shall have no obligation under this Agreement to maintain in confidence any information that: (i) is in the public domain at
the time of disclosure; (ii) though originally Confidential Information, subsequently enters the public domain other than by breach of
Executive’s obligations hereunder or by breach of another person’s or entity’s confidentiality obligations; or (iii)
is shown by documentary evidence to have been known by Executive prior to disclosure to Executive by the Company. Executive is also advised
that the misappropriation of trade secrets (a form of Confidential Information, as defined herein) is a violation of law, just like the
theft of any property. In addition to state law remedies, the Defend Trade Secrets Act of 2016 (the “DTSA”) enables
a trade secret owner to bring a trade secret misappropriation case in federal court. The DTSA generally provides that an individual shall
not be held criminally or civilly liable under any federal or state trade secret law in the following circumstances: (A) where the individual
discloses trade secrets in confidence to a federal, state or local government official or to an attorney solely for the purpose of reporting
or investigating a suspected violation of law; or (B) where the disclosure is made in a sealed filing in a lawsuit or other proceeding.
In addition, the DTSA generally permits an individual to disclose trade secrets to the individual’s attorney in the course of pursuing
a lawsuit where the person alleges retaliation for reporting a suspected violation of the law (or uses the trade secret information in
such lawsuit, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except
pursuant to court order). The foregoing is a very generalized summary of the immunity provisions of the DTSA intended to satisfy the notification
requirements of the DTSA. The DTSA does not preclude the trade secret owner from seeking breach of contract remedies, however. Executive
agrees to seek legal counsel before disclosing any trade secrets if Executive intends to seek immunity under the DTSA.

  

(c)     Third Party Information.
Executive recognizes that the Company may have received, and in the future may receive, from third parties their confidential or proprietary
information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain
limited purposes. Executive agrees that Executive owes the Company and such third parties, during Executive’s employment by the
Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose
it to any person or firm and to use it in a manner consistent with, and for the limited purposes permitted by, the Company’s agreement
with such third party. Notwithstanding the foregoing, Executive may disclose information following receipt of a Court Order requiring
disclosure, but only if he first provides the Company with the prompt notice of the Court Order so that it can object and seek to prevent
such disclosure.

 

(d)     Return of Confidential
Material. In the event of Executive’s termination of employment with Company for any reason whatsoever, Executive agrees promptly
to destroy or surrender and deliver to Company all records, notes, materials, equipment, drawings, documents and data of any nature pertaining
to any Confidential Information or to his employment, and Executive will not retain or take with him any tangible materials containing
or pertaining to any Confidential Information that Executive may produce, acquire or obtain access to during the course of his employment
except for copies of Executive’s own employment records. At the Company’s request, Executive will certify in writing that
Executive has destroyed or returned, as applicable, all Confidential Information in Executive’s possession.

 

	12. 	Intellectual Property. 

 

Executive agrees that all registered intellectual property,
including such registered items that are reduced to writing or specifically identified by the parties, and may include registered intellectual
property, specifically identified, such as inventions, innovations, improvements, technical information, trade secrets, systems, software
developments, ideas, results, methods, designs, artwork, analyses, drawings, reports, copyrights, service marks, trademarks, trade names,
logos and all similar or related information (whether patentable or unpatentable) which relate to the Company’s or any of its subsidiaries’
or affiliates’ businesses, research and development or existing or future products or services and which are conceived, developed
or made by Executive during his employment with the Company, together with all intellectual property rights therein, including, without
limitation, any patent applications, letters patent, trademark, trade name and service mark applications or registrations, copyrights
and reissues thereof that may be granted for or upon any of the foregoing (collectively referred to herein as “Work Product”),
shall be the sole and exclusive property of the Company.

 

 

    	3  

    	 

    

 

For the avoidance of doubt and without limiting the
foregoing, (a) the Company shall be the sole owner of all right, title and interest in such Work Product, including all intellectual property
rights relating to such Work Product, without Executive retaining any license or other residual right whatsoever, and (b) any rights to
any new or existing Work Product are automatically conveyed, assigned and transferred to the Company pursuant to this agreement. Executive
hereby waives and renounces all moral rights related, directly or indirectly, to any such existing or new Work Product. Executive will
take reasonable steps to promptly disclose such Work Product to the Company’s Board and perform all actions reasonably requested
by the Company (whether during or after the employment) to establish and confirm such ownership (including the execution and delivery
of assignments, consents, powers of attorney and other instruments) and to provide reasonable assistance to the Company in connection
with the prosecution of any applications for patents, trademarks, trade names, service marks or reissues thereof or in the prosecution
or defense of interferences relating to any Work Product. Executive agrees that any such copyrightable work is work made for hire by Executive
for the Company. To the extent that the immediately preceding sentence does not apply to any Work Product, Executive hereby irrevocably
assigns to the Company, for no additional consideration, Executive’s entire right, title and interest in and to all Work Product
and rights therein, including the right to sue, counterclaim and recover for all past, present and future infringement, misappropriation
or dilution thereof, and all rights corresponding thereto throughout the world. Executive agrees that this Agreement does not, and shall
not be construed to, grant Executive any license or right of any nature with respect to the Work Product or any Confidential Information,
materials, software or other tools made available to Executive by the Company.

  

	13. 	Termination of Employment.

 

(a)     By Company without
Cause. The Company may terminate Executive’s employment at any time, with or without cause or advance notice. However, if the
Company terminates Executive’s employment without Cause, as that term is defined in Section 13(b) below, or if Executive resigns
his employment for Good Reason, as that term is defined in Section 13(c) below, Executive will receive an amount equal to his base salary
for six (6) months or for the remainder of the Contract Term, whichever is less, together with (a) any other earned but unpaid amounts
due under the terms of this Agreement and (b) employee benefits for the applicable severance benefit period (the “Severance Benefits”).
To be eligible for Severance Benefits, Executive will be required to sign and not revoke a General Release in a form provided by the Company,
on or within 52 days after his final date of employment, as a condition of receiving Severance Benefits. Severance Benefits will be paid
in equal installment payments payable in accordance with the Company’s normal payroll practices, but no less frequently than monthly,
commencing within 60 days following the termination date subject to the potential delay due to the application of Section 13(f) . To the
extent that any severance payments are deferred compensation under Internal Revenue Code Section 409A, and are not otherwise exempt from
the application of Section 409A, then, if the period during which Executive may consider and sign the release spans two calendar years,
the payment of severance will not be made or begin until the later calendar year.

 

(b)     By Company for
Cause. For purposes of this Agreement, “Cause” will mean (i) Executive’s willful failure or refusal
to perform a lawful directive of the Board of Directors that is consistent with Executive’s duties and responsibilities, provided
the Company provides Executive with written notice of such failure or refusal and such failure or refusal is not cured within 14 days
of receipt of such notice, provided that if it is not possible to cure such failure or refusal within the 14-day period the Executive
shall have a reasonable period (not to exceed 60 days) within which to cure the failure or refusal; (ii) Executive’s material misconduct
or material violation of his fiduciary obligations or other duties owed to the Company; (iii) Executive’s performance of his duties
in a grossly negligent manner, or violation of any law or regulation that may affect Executive’s ability to perform his duties or
that is likely to harm the Company’s reputation; (iv) Executive’s conviction of or plea of no contest to any felony or
commission of any act, whether or not a felony, that has a material adverse effect on his ability to perform his duties; (v) Executive’s
material breach of this Agreement, or Company Policies that apply to him subject to notice and right to cure as in clause (i) above. If
Executive’s employment is terminated for Cause, he shall not be entitled to Severance Benefits or payment of any outstanding Bonus,
and shall receive only unpaid base salary for services rendered through the date of termination and payment for accrued and unused vacation.
Such payment shall be made in a single lump-sum payment on the date of Executive’s termination.

 

 

    	4  

    	 

    

 

 

(c)     Executive’s
Resignation for Good Reason. For purposes of this Agreement, “Good Reason” will mean that Executive resigns his
employment within the Contract Term as result of: (i) a material diminution in the Executive’s base compensation; (ii) a material
diminution in the Executive’s authority, duties, or responsibilities; (iii) a change in geographic location at which the Executive
must perform the services to any location outside Nevada; or (iv) any other action or inaction that constitutes a material breach of the
terms of this Agreement. Notwithstanding the foregoing, in no event shall such resignation constitute “Good Reason” unless
and until Executive provides written notice to the chairman of the Board of Directors of the existence of the good reason condition, which
notice must be within 90 days of its initial existence, and Executive provides the Company with at least 30 days to remedy the good reason
condition. If the condition is not remedied, the Executive must terminate his employment within sixty (60) days following the expiration
of such remedy period for the termination to be on account of a “Good Reason.”

 

If Executive resigns for Good Reason, he will receive
the Severance Benefits.

 

(d)     Death. Executive’s
employment and the Company’s obligations under this Agreement shall terminate automatically, effective immediately and without any
notice being necessary, upon Executive’s death. Executive’s legal representative shall receive unpaid compensation for Executive’s
services rendered through the date of termination and payment for accrued and unused vacation, which shall be paid in a single lump-sum
payment on or before 30 days after Executive’s death.

 

(e)     Disability.
In the event of Executive’s Disability, as defined below, Company shall have the right to terminate Executive’s employment
consistent with federal and state laws relating to the rights of persons with disabilities.

 

For purposes of this Agreement, “Disability”
will mean the Executive has been unable by reason of any mental or physical impairment to perform the essential functions of his position
for 120 days (whether or not consecutive) during any period of 360 days. A determination of disability shall be made by the
Company in consultation with a physician satisfactory to the Executive and the Company, and Executive shall cooperate with the efforts
to make such determination. Any such determination shall be conclusive and binding on the parties for the purpose of this Agreement. Any
determination of Disability under this Section 13(e) is not intended to alter any benefits Executive may be entitled to receive under
any long-term disability insurance policy carried by either the Company or Executive, which benefits shall be governed solely by the terms
of any such insurance policy.

 

(f)     Section
409A. Although the Company does not have a duty to design its compensation policies in a manner that minimizes Executive’s tax
liabilities, the payment of any Severance Benefits under this Section 16 is intended to comply with the requirements of Internal Revenue
Code Section 409A and final Treasury regulations promulgated thereunder. In no event shall the Executive have the ability to affect the
timing of the payment of Severance Benefits by acceleration, deferral, or otherwise. If the payment of any Severance Benefits is not exempt
under Section 409A and applicable regulations, this Agreement (and any definitions hereunder) will be construed in a manner that complies
with Section 409A, and incorporates by reference all required definitions and payment terms. In the event any of the payments to be made
to Executive upon the termination of employment are “deferred compensation” within the meaning of Section 409A, such payment
shall be delayed for six months and one day if Executive is a “specified person” for such 409A purposes. No interest shall
be due on any amounts deferred pursuant to this Section 13(f). 

 

	14. 	Successors and Assigns.

 

This Agreement shall be binding upon the parties hereto
and their respective heirs, executors, legal representatives, successors and assigns. This Agreement is specific to Executive and may
not be assigned.

 

	15. 	Waiver and Amendment.

 

No modification, waiver or amendment of this Agreement
will be effective unless in writing signed by the Executive and by the Company. No waiver by either party of any condition or provision
of this Agreement shall be considered a waiver of any other condition or provision or a waiver of the same condition or provision at another
time.

 

	16. 	Entire Agreement.

 

This Agreement sets forth the entire Agreement and
understanding between the Company and Executive relating to the subject matters herein and supersedes all prior or contemporaneous discussions
and Agreements between the parties, whether oral or written.

 

    	5  

    	 

    

 

 

	17. 	Governing Law.

 

This Agreement shall be governed by the laws of the
State of Nevada.

 

	18. 	Severability.

 

The invalidity or unenforceability of one or more provisions
of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and
effect to the maximum extent of the law.

 

	19. 	Arbitration.

 

Any and all claims, controversies
or disputes arising out of or relating to this Agreement, or the breach thereof, which remain unresolved after direct negotiations between
Executive and the Company, shall first be submitted to confidential Mediation in Nevada in accordance with the Rules, Procedures and Protocols
for Mediation of Disputes of Dispute Prevention & Resolution, Inc. (“DPRI”), then in effect. If any issues, claims
or disputes remain unresolved after mediation concludes, Executive and the Company agree to submit any such issues to binding arbitration
in Nevada before one arbitrator in accordance with the Rules, Procedures and Protocols for Arbitration of Disputes of DPRI, then in
effect. However, Executive and the Company agree that the foregoing shall not preclude either of them from seeking any injunctive or equitable
relief from a court of competent jurisdiction pursuant to any provision of this Agreement. Executive and the Company each further agree
that, subject to Chapter 658A, Nevada Revised Statutes, as the same may hereafter be amended or recodified, the award of the arbitrator(s)
shall be binding upon each of them and that judgment upon the award rendered may be entered in any court of competent jurisdiction.  

 

	20.	Counterparts.

 

This Agreement may be executed in counterparts, each
of which shall be deemed an original, but all of which together will constitute one and the same instrument.

 

[Signature page follows]

 

 

 

    	6  

    	 

    

 

The directors of cDistro, Inc., who have approved the
terms of this Agreement, are very pleased that you have agreed to lead the Company and are enthusiastic about the prospects for the Company
under your leadership. Please acknowledge your agreement with, and acceptance of, the foregoing terms by signing below where indicated.
A copy of this Agreement will be filed with the Securities and Exchange Commission as a public document.

 

	
    cDistro, Inc.

     

    _/s/ Ronald P. Russo, Jr.____________________

    By: Ronald P. Russo, Jr.

    Its: Chief Executive Officer

    Date:

     
	
    Executive

     

    _/s/ Ronald P. Russo, Jr.____________________

    By: Ronald P. Russo, Jr.

    Date:

 

 

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]